Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2026-01-12 Regulatory Filings
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - LGP 5 pages 17.7KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of conditional rights to securities for LITTLE GREEN PHARMA LTD. It provides specific information about securities that have ceased, including ASX security codes, number of securities ceased, reasons for cessation, and dates. The document is a formal announcement to the ASX about changes in the company's issued capital due to cessation of securities. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement about securities cessation, fitting the category of Regulatory Filings (RNS) as it does not fit other more specific categories like Share Issue/Capital Change (SHA) which typically involves new issues or capital changes rather than cessation/lapse of rights. The document length is moderate and contains detailed cessation information, confirming it is not a brief report publication announcement or a certification. Therefore, the best classification is Regulatory Filings (RNS).
2026-01-12 English
US Executive Order to reschedule cannabis 2 pages 229.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 22 December 2025 from Little Green Pharma Ltd. It discusses a recent US Executive Order to reschedule cannabis under the US Controlled Substances Act, highlighting industry implications and company outlook. The content is a news update or commentary on regulatory changes affecting the company and its sector, rather than a financial report, earnings release, or management discussion. The document is relatively short (4383 characters) and does not contain financial statements or detailed financial data. It is an announcement informing investors about a significant regulatory development and its potential impact on the company and industry. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2025-12-21 English
Half Yearly Report and Accounts 28 pages 605.3KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half Year Financial Report' and references the half-year ended 30 September 2025. It contains detailed financial statements including profit or loss, cash flows, balance sheet, notes to the financial statements, and an auditor's review report. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement. Therefore, the appropriate classification is 'Interim / Quarterly Report' (IR). H1 2026
2025-11-20 English
Appendix 3Y correction 5 pages 407.2KB
Director's Dealing Classification · 100% confidence The document is an ASX announcement titled 'Appendix 3Y correction' related to a correction of a previously lodged Appendix 3Y form. Appendix 3Y is a 'Change of Director’s Interest Notice' which reports changes in securities holdings by company directors. The document details the correction of the number of unlisted options held by a director, Fleta Jennifer Solomon, and includes detailed tables of securities held before and after the change. There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement about insider shareholdings by a director, which fits the category of Director's Dealing filings. The length and content confirm it is not a brief notice or a report publication announcement but a substantive disclosure of director's securities transactions.
2025-11-13 English
September 2025 Quarterly & Appendix 4C Investor Presentation 20 pages 4.3MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'September 2025 Quarterly & Appendix 4C Investor presentation' and contains detailed financial and operational data for the quarter ending 30 September 2025. It includes revenue figures, cash flow data, segment and product category breakdowns, market updates, and other substantive financial and business information. The presence of quarterly financial data and analysis indicates this is a comprehensive interim report rather than a brief announcement or presentation only. The document is about a quarter's performance, consistent with an Interim / Quarterly Report. It is not a full annual report (10-K), nor is it a short earnings release or a simple investor presentation. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2026
2025-11-11 English
Investor Webinar Invitation 2 pages 399.5KB
Investor Presentation Classification · 90% confidence The document is an ASX announcement inviting shareholders to an investor webinar presentation scheduled for November 12, 2025. It mentions that the presentation will cover the company's September quarterly results and other business updates. The document does not contain actual financial statements or detailed financial analysis but rather serves as an invitation and overview of the upcoming event. The length is under 5,000 characters and it is primarily an announcement of a presentation rather than the presentation or report itself. Therefore, it fits best as an Investor Presentation (IP) announcement rather than a full Interim/Quarterly Report (IR) or Earnings Release (ER). Given the content and purpose, the classification is Investor Presentation (IP) with high confidence.
2025-11-04 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.